Atlas Trials

Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer

Clinical trial NCT02453009 · COMPLETED

Trial details

NCT number
NCT02453009
Sponsor
Santa Chiara Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2014-10-01
Primary completion
2018-04-01
Enrollment
246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.